异动解读 | 多家投行下调目标价,Inspire Medical Systems盘前大跌18.6%

异动解读
May 05

Inspire Medical Systems(INSP)今日盘前股价大跌18.6%,引发了市场的广泛关注。

消息面上,多家华尔街投行在同一天下调了该公司的目标价。摩根大通将目标价从67美元下调至54美元,Leerink Partners将目标价从78美元下调至52美元,RBC将目标价从56美元下调至45美元,Truist Securities将目标价从64美元下调至50美元。

分析师集体下调目标价通常反映了对公司未来增长前景或财务状况的担忧,这直接影响了投资者的信心,导致盘前交易中出现显著的抛售压力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10